Skip To Main Content

JLCD Administering Medicines to Students

File: JLCD
 
ADMINISTERING MEDICINES TO STUDENTS 

Medication may not be administered to students while at school unless such medicine is given to them by the school nurse acting under specific written request of the parent or guardian and under the written directive of the student's personal physician (see below for exceptions). No one but the school nurse, and those others listed in the medical administration plan may give any medication to any student. 
 
Exceptions
The school district shall, through the district nurse leader, register with the Dept. of Public Health and train personnel in the use of epinephrine auto-injectors. 
The school district may, in conjunction with the School Physician and the School Nurse Leader, stock nasal naloxone (Narcan) and trained medical personnel and first responders may administer nasal naloxone to individuals experiencing a life threatening opiate overdose in a school setting.  
 
If the school district wishes medical personnel to train non-medical staff in the administration of nasal naloxone, the School Committee shall vote to approve such training and the Superintendent shall ensure that medical personnel have a written protocol which complies with medical directives and regulations from the Dept. of Public Health.
 
Following consultation with the school nurse, students who fall into the following exceptions may self-administer medications: 
 
  1. Students with asthma or other respiratory diseases may possess and administer prescription inhalers.
  2. Students with cystic fibrosis may possess and administer prescription enzyme supplements.
  3. Students with diabetes may possess and administer glucose monitoring tests and insulin delivery systems.
  4. Students with life threatening allergies may possess and administer epinephrine.
  5. Other situations where a student may self-administer medications will be outlined in the student’s medical administration plan, as approved by the school nurse.
LEGAL REFS.:  
 
Adopted: 12/1/2022

Section J: